Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Dendritic Hydrogels Help Eradicate Bacterial Pathogens

By HospiMedica International staff writers
Posted on 28 Oct 2021
A new study reports on unique antibiotic-free hydrogels that induce immune modulation in human keratinocytes, providing an effective solution against a broad spectrum of bacteria.

Developed at KTH Royal Institute of Technology (KTH; Stockholm, Sweden), Karolinska Institutet (Solna, Sweden), and other institutions, the new H10K-G5 cationic hydrogel is based on hyperbranched dendritic–linear–dendritic copolymers (HBDLDs). More...
Resembling trees, the dendritic polymers' branches terminate with numerous peripheral contact points carrying a cationic charge which interact strongly with negatively-charged bacterial cell membranes. The hydrogels are formed spontaneously when sprayed on wounds, and are 100% degradable and non-toxic.

In the study, H10K-G5 exhibited excellent antimicrobial activity to a wide range of clinical Gram-positive and Gram-negative bacteria, including drug-resistant strains isolated from wounds. H10K-G5 works by inducing expression of the antimicrobial peptides RNase 7 and psoriasin, promoting host-mediated bacterial killing in human keratinocytes. It also decreases pro-inflammatory cytokine IL-1β, reactive nitrogen species, and mitochondrial reactive oxygen species (ROS) in S. aureus-infected keratinocytes, conjunctively resulting in reduced inflammation. The study was published on October 12, 2021, in Journal of the American Chemical Society (JACS).

“Bacterial cells are interactive, and so are dendritic macromolecules. When they meet, it doesn't turn out well for the bacteria,” said co-senior author Professor Annelie Brauner, PhD, of Karolinska Institutet. “Contrary to traditional antibiotics, resistance towards antimicrobial peptides is very rarely seen. The gel is an outstanding contribution in the fight against multidrug-resistant bacteria, especially in current times, when we are running out of available antibiotics.”

Infections caused by antibiotic-resistant bacteria are a major global threat, leading to high mortality rates and increased economic burden. Novel treatment strategies are therefore urgently needed by healthcare providers. Biomaterials such as HBDLDs, which are based on polyethylene glycol (PEG) and propionic acid (bis-MPA), with inherent antibacterial properties, which do not require the use of antibiotics, present an attractive and feasible avenue to achieve this goal.

Related Links:
KTH Royal Institute of Technology
Karolinska Institutet



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.